Ibrutinib does not have clinically relevant interactions with oral contraceptives or substrates of CYP3A and CYP2B6
Palabras clave :
Cytochrome P450
Drug interactions
Pharmacokinetics
Phase I
Fecha de publicación :
2020
Nota:
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in
any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Cita:
de-Jong, J. (Jan); Mitselos, A. (Anna); Jurczak, W. (Wojciech); et al. "Ibrutinib does not have clinically relevant interactions with oral contraceptives or substrates of CYP3A and CYP2B6". Pharmacology Research and Perspectives. 8 (5), 2020,
Aparece en las colecciones:
Estadísticas e impacto
0 citas en
0 citas en
Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.